DE2704329A1 - Therapeutisches mittel - Google Patents

Therapeutisches mittel

Info

Publication number
DE2704329A1
DE2704329A1 DE19772704329 DE2704329A DE2704329A1 DE 2704329 A1 DE2704329 A1 DE 2704329A1 DE 19772704329 DE19772704329 DE 19772704329 DE 2704329 A DE2704329 A DE 2704329A DE 2704329 A1 DE2704329 A1 DE 2704329A1
Authority
DE
Germany
Prior art keywords
polymer
molecular weight
units
product according
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19772704329
Other languages
German (de)
English (en)
Inventor
Fred Easterday Boettner
Sidney Melamid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohm and Haas Co
Original Assignee
Rohm and Haas Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm and Haas Co filed Critical Rohm and Haas Co
Publication of DE2704329A1 publication Critical patent/DE2704329A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F12/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F12/02—Monomers containing only one unsaturated aliphatic radical
    • C08F12/04—Monomers containing only one unsaturated aliphatic radical containing one ring
    • C08F12/14—Monomers containing only one unsaturated aliphatic radical containing one ring substituted by hetero atoms or groups containing heteroatoms
    • C08F12/30—Sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/10—Copolymer characterised by the proportions of the comonomers expressed as molar percentages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/20—Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19772704329 1976-02-04 1977-02-02 Therapeutisches mittel Ceased DE2704329A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65520076A 1976-02-04 1976-02-04
US75269376A 1976-12-20 1976-12-20

Publications (1)

Publication Number Publication Date
DE2704329A1 true DE2704329A1 (de) 1977-08-18

Family

ID=27096927

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772704329 Ceased DE2704329A1 (de) 1976-02-04 1977-02-02 Therapeutisches mittel

Country Status (10)

Country Link
JP (1) JPS5296748A (xx)
AU (1) AU514389B2 (xx)
CA (1) CA1114997A (xx)
DE (1) DE2704329A1 (xx)
DK (1) DK44777A (xx)
FR (1) FR2340330A1 (xx)
GB (1) GB1576016A (xx)
IE (1) IE44690B1 (xx)
NL (1) NL7701168A (xx)
SE (2) SE430070B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395392A (en) * 1980-06-24 1983-07-26 Adria Laboratories Inc. Method for treating kidney stones
US4375461A (en) * 1980-07-25 1983-03-01 Johnson & Johnson Products, Inc. Sulfonated vinyl aromatic homopolymers and copolymers as dental plaque barriers
US4432967A (en) * 1982-06-25 1984-02-21 National Starch And Chemical Corp. Contraceptive composition
EP0579153B1 (en) * 1992-07-13 1998-04-08 Tosoh Corporation Process for producing tertiary alcohols
US6290946B1 (en) * 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
EP1800686A3 (en) * 1999-05-13 2009-12-30 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
US6270755B1 (en) 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
CA2314494A1 (en) 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Anionic polymers as species specific antibacterial agents
WO2003099881A1 (en) * 2001-01-11 2003-12-04 Sony Corporation Ion-conductive polymer, solid polyelectrolyte, and cell employing the same
AU2003254007B2 (en) * 2002-07-22 2007-08-23 Genzyme Corporation Poly (potassium and sodium styrene sulfonate), its manufacture and its uses
AU2003903547A0 (en) * 2003-07-10 2003-07-24 Neoferma Australia Pty Ltd Structures and methods of waterproofing same
JP6271378B2 (ja) * 2014-09-05 2018-01-31 信越化学工業株式会社 導電性ポリマー用高分子化合物及びその製造方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3310481A (en) * 1962-09-10 1967-03-21 Dow Chemical Co Removal of residual monomeric sulfonates from polymerizates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4936644A (xx) * 1972-08-15 1974-04-05

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3310481A (en) * 1962-09-10 1967-03-21 Dow Chemical Co Removal of residual monomeric sulfonates from polymerizates thereof

Also Published As

Publication number Publication date
AU2193477A (en) 1978-08-10
IE44690L (en) 1977-08-04
FR2340330A1 (fr) 1977-09-02
AU514389B2 (en) 1981-02-05
SE8106138L (sv) 1981-10-16
GB1576016A (en) 1980-10-01
SE7700670L (sv) 1977-08-05
NL7701168A (nl) 1977-08-08
SE426835B (sv) 1983-02-14
IE44690B1 (en) 1982-02-24
SE430070B (sv) 1983-10-17
DK44777A (da) 1977-08-05
CA1114997A (en) 1981-12-22
FR2340330B1 (xx) 1981-05-29
JPS5296748A (en) 1977-08-13

Similar Documents

Publication Publication Date Title
DE69818058T2 (de) Verwendung von polyallylamin-polymeren zur herstellung eines medikamentes zur behandlung von hypercholesterolemia
DE2835145A1 (de) Substanz zum behandeln von nierensteinen
DE2704329A1 (de) Therapeutisches mittel
DE68914810T2 (de) Vinylpyridinium vernetztes Polymer.
DE1543579B2 (de) Bis-Chromonylverbindungen und deren pharmakologisch nicht giftigen Salze oder niedrige Alkylester und Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH640249A5 (de) Germaniumhaltiges organisches polymer und verfahren zu seiner herstellung.
EP0472501B1 (de) Codeinsalz einer substituierten Carbonsäure, Verfahren zu seiner Herstellung, seine Verwendung und pharmazeutische Präparate
DE2659580A1 (de) Entzuendungshemmendes mittel
DE2040578C3 (de) Analgetisch, antiinflammatorisch und antiulcerogen wirkendes Arzneimittel
US4395392A (en) Method for treating kidney stones
CH644874A5 (de) Copolymere aus olefinen und alpha,beta-ungesaettigten polycarbonsaeureanhydriden, verfahren zu ihrer herstellung und ihre verwendung.
DE2333211C2 (xx)
DE2732929A1 (de) Polyaether, verfahren zu ihrer herstellung sowie ihre verwendung als lipidabsorptionshemmer
DE1915497C3 (de) Arzneimittel mit hypolipidaemischer und hypocholesterinaemischer Wirksamkeit
DE2461985C3 (de) Pepsininhibierendes Arzneimittel
DE2104851C3 (de) Verwendung von Acrylsäure-Polymerisaten bei der Behandlung von Hypersekretion des Magens oder Duodenums
CH644596A5 (de) 2,6-dimethyl-1,4-dihydropyridin-3,5-dikarbonsaeureester und verfahren zu ihrer herstellung.
DE1543733C3 (de) Aluminium-bis-alpha-(p-chlorphenoxy) isobutyrat und diese Verbindung als Wirkstoff enthaltende Hellmittel
DE2511576C2 (de) Metformin-clofibrat, Verfahren zu seiner Herstellung und dieses enthaltendes Arzneimittel
DE2320945A1 (de) Neue ester der acetylsalicylsaeure
CH671880A5 (xx)
DE2708327A1 (de) Entzuendungshemmendes mittel
DE2839311C2 (de) Pharmazeutisches Präparat gegen Geschwüre
DE2345291A1 (de) Therapeutisches mittel
DE550573C (de) Verfahren zur Herstellung von Arsen und Antimon enthaltenden Wismutverbindungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: MUELLER-BOERNER, R., DIPL.-ING., 1000 BERLIN WEY,

8131 Rejection